Spirazen 3 Tablet contains Spiramycin 3 Million IU, a well-established macrolide antibiotic effective against a wide range of gram-positive and intracellular bacterial infections. It is commonly prescribed for respiratory tract infections, ENT infections, oral and dental infections, and certain parasitic infections such as toxoplasmosis.
Spiramycin works by inhibiting bacterial protein synthesis, thereby stopping the growth and multiplication of pathogenic organisms. Its high-strength 3 Million IU dosage ensures strong antimicrobial action, making it suitable for moderate to severe infections requiring reliable antibiotic therapy.
For hospitals, clinics, and pharmaceutical distributors, Spirazen 3 Tablet is a high-rotation antibiotic, widely used in general medicine, dentistry, gynecology, and infectious disease management. Its consistent prescription ensures stable demand across outpatient and institutional healthcare settings.
Adding Spirazen 3 Tablet to your product portfolio strengthens your anti-infective and antibiotic segment, opening opportunities in hospital procurement, pharmacy distribution, export markets, institutional supply, and third-party manufacturing. Its proven clinical effectiveness makes it a dependable and commercially valuable product for pharmaceutical distributors.